[go: up one dir, main page]

AR056835A1 - Composicion que contiene oligosacaridos - Google Patents

Composicion que contiene oligosacaridos

Info

Publication number
AR056835A1
AR056835A1 ARP060105380A ARP060105380A AR056835A1 AR 056835 A1 AR056835 A1 AR 056835A1 AR P060105380 A ARP060105380 A AR P060105380A AR P060105380 A ARP060105380 A AR P060105380A AR 056835 A1 AR056835 A1 AR 056835A1
Authority
AR
Argentina
Prior art keywords
childhood
infection
oligosacarids
prevention
treatment
Prior art date
Application number
ARP060105380A
Other languages
English (en)
Inventor
Van Tland Belinda Potappel
Johan Garssen
Gunther Boehm
Bernd Stahl
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of AR056835A1 publication Critical patent/AR056835A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de mezclas de oligosacáridos para el tratamiento yo prevencion de infecciones, en particular para reducir la gravedad de una infeccion de la infancia o para el tratamiento y/o prevencion de una infeccion de la infancia. Reivindicacion 1: Uso de sacáridos de ácido uronico, preferentemente combinados con oligosacáridos neutros, caracterizado porque se refiere a la produccion de una composicion farmacéutica o nutricional para reducir la gravedad de una infeccion de la infancia o para el tratamiento y/o prevencion de una infeccion de la infancia.
ARP060105380A 2005-12-06 2006-12-06 Composicion que contiene oligosacaridos AR056835A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2005/050064 WO2007067033A1 (en) 2005-12-06 2005-12-06 Composition containing oligosaccharides for the treatment/ prevention of infections

Publications (1)

Publication Number Publication Date
AR056835A1 true AR056835A1 (es) 2007-10-24

Family

ID=35695482

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105380A AR056835A1 (es) 2005-12-06 2006-12-06 Composicion que contiene oligosacaridos

Country Status (10)

Country Link
US (3) US20090156550A1 (es)
EP (1) EP1957084B1 (es)
CN (1) CN101336108A (es)
AR (1) AR056835A1 (es)
AU (1) AU2006323322B2 (es)
BR (1) BRPI0619464A2 (es)
CA (1) CA2632664A1 (es)
MY (1) MY147371A (es)
RU (1) RU2420296C2 (es)
WO (2) WO2007067033A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009096772A1 (en) 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
EP2293677B1 (en) 2008-06-13 2017-11-15 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
ES2904608T3 (es) 2009-07-15 2022-04-05 Nutricia Nv Fucosil lactosa como oligosacárido no digerible idéntico al de la leche materna para tratar y/o prevenir la diarrea vírica
CN106509916A (zh) * 2010-04-27 2017-03-22 N·V·努特里奇亚 人乳寡糖在婴儿营养物中的用途
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
RU2663065C2 (ru) 2013-11-04 2018-08-01 Н.В. Нютрисиа Ферментированное детское питание с неперевариваемыми олигосахаридами
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
KR20210058854A (ko) * 2018-09-06 2021-05-24 프리슬랜드캄피나 네덜란드 비.브이. 비피더스 활성 저알레르기성 gos 조성물 및 락토바실러스 델브루에키 ssp 불가리쿠스의 균주로부터의 베타-갈락토시다제를 수반하는 이의 제공 방법
CN111249288B (zh) * 2019-12-27 2021-09-17 浙江医院 甘露葡萄糖醛酸寡糖及其衍生物在制备治疗和/或预防hcmv药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
PL1733730T3 (pl) * 2003-10-24 2008-12-31 Nutricia Nv Oligosacharydy immunomodulujące
EP1714660A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics

Also Published As

Publication number Publication date
BRPI0619464A2 (pt) 2011-10-04
AU2006323322B2 (en) 2012-08-09
AU2006323322A2 (en) 2008-07-10
EP1957084B1 (en) 2013-09-04
MY147371A (en) 2012-11-30
CA2632664A1 (en) 2007-06-14
EP1957084A1 (en) 2008-08-20
CN101336108A (zh) 2008-12-31
WO2007067033A1 (en) 2007-06-14
US20090156550A1 (en) 2009-06-18
RU2420296C2 (ru) 2011-06-10
AU2006323322A1 (en) 2007-06-14
RU2008127326A (ru) 2010-01-20
WO2007067053A9 (en) 2007-10-04
US20130109650A1 (en) 2013-05-02
US20120122813A1 (en) 2012-05-17
WO2007067053A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
AR058133A1 (es) Metodo de tratamiento y/o prevencion de infecciones en bebes nacidos por cesarea
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
UA103750C2 (ru) Применение пробиотических бактерий в качестве добавок к рациону беременных женщин
AR061989A1 (es) Combinacion de peroxido de adapaleno y benzoilo para el tratamiento de lesiones de acne
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
AR056835A1 (es) Composicion que contiene oligosacaridos
BRPI0516751A (pt) pirimidinas bicìclicas que inibem hcv
PE20061016A1 (es) Una formulacion solida de dosificacion farmaceutica
MY160703A (en) Crystalline forms of (r) -5- [3-chloro-4-(2,3-dihydroxy) - benz [z] ylidene] -2- ([z]-propylimino) -3-0-tolyl-thiazolidin-4-one
CL2008000411A1 (es) Composicion farmaceutica que comprende un primer compuesto que incrementa el ph del estomago, un segundo agente que reduce el ph y al menos un tercer agente seleccionado entre una vitamina, un mineral y otro farmaco; y su uso para mejorar la absorcio
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
CL2008001549A1 (es) Complejo de hierro soluble en agua con maltodextrinas derivatizadas y oxidadas en c1; procedimiento para su preparacion; composicion farmaceutica; y su uso para el tratamiento o profilaxis de anemias de deficiencia de hierro.
GT200600520A (es) Agentes antibacterianos
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
CL2008002758A1 (es) Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento.
PH12014500344A1 (en) Composition for use in the promotion of magnesium absorption and/or magnesium retention
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
DE602006017724D1 (de) Salicylsäurederivate
BRPI0608328A2 (pt) uso de lactobacillus rhamnosus gg para tratamento, prevenção ou redução de inflamação sistêmica em um bebê alimentado com fórmula
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
BRPI0611526A2 (pt) composição tópica contendo gelatina
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections

Legal Events

Date Code Title Description
FA Abandonment or withdrawal